Literature DB >> 10944646

Appropriateness of rabies postexposure prophylaxis treatment for animal exposures. Emergency ID Net Study Group.

G J Moran1, D A Talan, W Mower, M Newdow, S Ong, J Y Nakase, R W Pinner, J E Childs.   

Abstract

CONTEXT: Rabies postexposure prophylaxis (RPEP) treatments and associated costs have increased in the United States. The extent to which RPEP use is consistent with guidelines is not well understood.
OBJECTIVE: To characterize animal contacts and determine the frequency and factors associated with inappropriate RPEP use. DESIGN, SETTING, AND PATIENTS: Prospective case series study of patients presenting with an animal exposure-related complaint from July 1996 to September 1998 at 11 university-affiliated, urban emergency departments (the Emergency ID Net). MAIN OUTCOME MEASURES: Exposure type, circumstances, and RPEP use (appropriateness defined by local public health departments).
RESULTS: Of 2030 exposures, 1635 (81%) were to dogs; 268 (13%) to cats; 88 (4%) to rodents/rabbits; 10 (0. 5%) to raccoons; 5 (0.2%) to bats; and 24 (1.2%) to other animals. Among those exposed, 136 (6.7%) received RPEP after dog (95), cat (21), raccoon (8), bat (4), or other animal (8) exposures. Use of RPEP varied by site (range, 0%-27.7% of exposures), with most frequent use reported at sites in the eastern United States. Management was considered appropriate in 1857 exposures (91.5%). Use of RPEP was considered inappropriate in 54 cases (40% of those in which it was given), owing to factors including animal availability for observation and exposure in a low-endemicity area. Rabies postexposure prophylaxis was considered inappropriately withheld from 119 cases (6.3% of those not receiving RPEP), often because a domestic animal was unavailable for observation or testing.
CONCLUSION: These results suggest that use of RPEP is often inappropriate. Greater compliance with current guidelines would increase RPEP use. Physician education, improved coordination with public health officials, and clarification of RPEP guidelines could optimize use of this expensive resource. JAMA. 2000;284:1001-1007

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944646     DOI: 10.1001/jama.284.8.1001

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  24 in total

1.  Human Rabies Postexposure Prophylaxis Knowledge and Retention Among Health Professionals by Using an Online Continuing Education Module: Arizona, 2012 to 2015.

Authors:  Heather Venkat; James Matthews; Jigna Narang; Rebecca Sunenshine; Laura E Adams; Andrean M Bunko; Jessica R White; Craig Levy; Tammy Sylvester
Journal:  Pedagogy Health Promot       Date:  2018-04-06

2.  Using an Emergency Department Syndromic Surveillance System to Evaluate Reporting of Potential Rabies Exposures, Illinois, 2013-2015.

Authors:  Kelley Bemis; Mabel Frias; Megan Toth Patel; Demian Christiansen
Journal:  Public Health Rep       Date:  2017 Jul/Aug       Impact factor: 2.792

3.  Post-exposure rabies prophylaxis in humans exposed to animals in Lublin province (Eastern Poland) in 2012-2015 - A retrospective study.

Authors:  Joanna Krzowska-Firych; Krzysztof Tomasiewicz; Agata Kozøowska
Journal:  Hum Vaccin Immunother       Date:  2017-02-06       Impact factor: 3.452

4.  Rabies in a nine-year-old child: The myth of the bite.

Authors:  Olivier Despond; Marisa Tucci; Hélène Decaluwe; Marie-Claude Grégoire; Jeanne S Teitelbaum; Nathalie Turgeon
Journal:  Can J Infect Dis       Date:  2002-03

5.  Postexposure treatment and animal rabies, Ontario, 1958-2000.

Authors:  Christopher P Nunan; Rowland R Tinline; Janet M Honig; David G A Ball; Peggy Hauschildt; Charles A LeBer
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

6.  Imported episodic rabies increases patient demand for and physician delivery of antirabies prophylaxis.

Authors:  Zélie Lardon; Laurence Watier; Audrey Brunet; Claire Bernède; Maryvonne Goudal; Laurent Dacheux; Yolande Rotivel; Didier Guillemot; Hervé Bourhy
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

7.  Estimating the risk of rabies transmission to humans in the U.S.: a Delphi analysis.

Authors:  Sagar A Vaidya; Susan E Manning; Praveen Dhankhar; Martin I Meltzer; Charles Rupprecht; Harry F Hull; Daniel B Fishbein
Journal:  BMC Public Health       Date:  2010-05-26       Impact factor: 3.295

8.  Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure.

Authors:  Nicholas Hobart-Porter; Michal Stein; Naveh Toh; Novinyo Amega; Huy-Binh Nguyen; James Linakis
Journal:  Hum Vaccin Immunother       Date:  2021-02-09       Impact factor: 4.526

9.  Terrestrial rabies and human postexposure prophylaxis, New York, USA.

Authors:  Millicent Eidson; Anissa K Bingman
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

10.  Public health impact of reemergence of rabies, New York.

Authors:  Hwa-Gan H Chang; Millicent Eidson; Candace Noonan-Toly; Charles V Trimarchi; Robert Rudd; Barbara J Wallace; Perry F Smith; Dale L Morse
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.